<VariationArchive VariationID="486929" VariationName="NM_000535.7(PMS2):c.119_122dup (p.Leu42fs)" VariationType="Duplication" Accession="VCV000486929" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-01" DateCreated="2018-01-01" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="474671" VariationID="486929">
      <GeneList>
        <Gene Symbol="PMS2" FullName="PMS1 homolog 2, mismatch repair system component" GeneID="5395" HGNC_ID="HGNC:9122" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7p22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="5970925" stop="6009106" display_start="5970925" display_stop="6009106" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="6012869" stop="6048736" display_start="6012869" display_stop="6048736" Strand="-" />
          </Location>
          <OMIM>600259</OMIM>
          <Haploinsufficiency last_evaluated="2015-11-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PMS2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-11-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PMS2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000535.7(PMS2):c.119_122dup (p.Leu42fs)</Name>
      <CanonicalSPDI>NC_000007.14:6005932:TCCTT:TCCTTCCTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7p22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="6005932" stop="6005933" display_start="6005932" display_stop="6005933" variantLength="4" positionVCF="6005932" referenceAlleleVCF="C" alternateAlleleVCF="CTCCT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="6045563" stop="6045564" display_start="6045563" display_stop="6045564" variantLength="4" positionVCF="6045563" referenceAlleleVCF="C" alternateAlleleVCF="CTCCT" />
      </Location>
      <ProteinChange>L42fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.6045565_6045568dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.6045565_6045568dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.6005934_6005937dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.6005934_6005937dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008466.1" sequenceAccession="NG_008466" sequenceVersion="1" change="g.8171_8174dup">
            <Expression>NG_008466.1:g.8171_8174dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_050738.1" sequenceAccession="NG_050738" sequenceVersion="1" change="g.1684_1687dup">
            <Expression>NG_050738.1:g.1684_1687dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000535.7" sequenceAccession="NM_000535" sequenceVersion="7" change="c.119_122dup" MANESelect="true">
            <Expression>NM_000535.7:c.119_122dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000526.2" sequenceAccession="NP_000526" sequenceVersion="2" change="p.Leu42fs">
            <Expression>NP_000526.2:p.Leu42fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322003.2" sequenceAccession="NM_001322003" sequenceVersion="2" change="c.-287_-284dup">
            <Expression>NM_001322003.2:c.-287_-284dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322005.2" sequenceAccession="NM_001322005" sequenceVersion="2" change="c.-287_-284dup">
            <Expression>NM_001322005.2:c.-287_-284dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322006.2" sequenceAccession="NM_001322006" sequenceVersion="2" change="c.119_122dup">
            <Expression>NM_001322006.2:c.119_122dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308935.1" sequenceAccession="NP_001308935" sequenceVersion="1" change="p.Leu42fs">
            <Expression>NP_001308935.1:p.Leu42fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322007.2" sequenceAccession="NM_001322007" sequenceVersion="2" change="c.-97_-94dup">
            <Expression>NM_001322007.2:c.-97_-94dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322009.2" sequenceAccession="NM_001322009" sequenceVersion="2" change="c.-287_-284dup">
            <Expression>NM_001322009.2:c.-287_-284dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322011.2" sequenceAccession="NM_001322011" sequenceVersion="2" change="c.-766_-763dup">
            <Expression>NM_001322011.2:c.-766_-763dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322012.2" sequenceAccession="NM_001322012" sequenceVersion="2" change="c.-766_-763dup">
            <Expression>NM_001322012.2:c.-766_-763dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322013.2" sequenceAccession="NM_001322013" sequenceVersion="2" change="c.-287_-284dup">
            <Expression>NM_001322013.2:c.-287_-284dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322014.2" sequenceAccession="NM_001322014" sequenceVersion="2" change="c.119_122dup">
            <Expression>NM_001322014.2:c.119_122dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308943.1" sequenceAccession="NP_001308943" sequenceVersion="1" change="p.Leu42fs">
            <Expression>NP_001308943.1:p.Leu42fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322015.2" sequenceAccession="NM_001322015" sequenceVersion="2" change="c.-366_-363dup">
            <Expression>NM_001322015.2:c.-366_-363dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_136154.1" sequenceAccession="NR_136154" sequenceVersion="1" change="n.206_209dup">
            <Expression>NR_136154.1:n.206_209dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322008.2" sequenceAccession="NM_001322008" sequenceVersion="2" change="c.-52-1878_-52-1875dup">
            <Expression>NM_001322008.2:c.-52-1878_-52-1875dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322010.2" sequenceAccession="NM_001322010" sequenceVersion="2" change="c.-242-1878_-242-1875dup">
            <Expression>NM_001322010.2:c.-242-1878_-242-1875dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322004.2" sequenceAccession="NM_001322004" sequenceVersion="2" change="c.-242-1878_-242-1875dup">
            <Expression>NM_001322004.2:c.-242-1878_-242-1875dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_161" sequenceAccession="LRG_161">
            <Expression>LRG_161:g.8171_8174dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000535.5" sequenceAccession="NM_000535" sequenceVersion="5" change="c.119_122dupAGGA">
            <Expression>NM_000535.5:c.119_122dupAGGA</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA658657659" DB="ClinGen" />
        <XRef Type="rs" ID="1554306391" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000535.7(PMS2):c.119_122dup (p.Leu42fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV000562369" Version="3">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-04-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-04-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-01-01" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1311590" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2018-01-01">
        <ClinVarSubmissionID localKey="a837781|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000676173" DateUpdated="2024-05-01" DateCreated="2018-01-01" Type="SCV" Version="5" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-04-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.119_122dupAGGA pathogenic mutation, located in coding exon 2 of the PMS2 gene, results from a duplication of 4 nucleotides at nucleotide position 119, causing a translational frameshift with a predicted alternate stop codon. Since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.5:c.119_122dupAGGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1311590" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

